|Home | About | Journals | Submit | Contact Us | Français|
The human rhodopsin (Rho) mutation T17M leads to autosomal dominant retinitis pigmentosa (adRP). The goal of our study was to elucidate the role of endoplasmic reticulum (ER) stress in retinal degeneration in hT17M Rho mice and identify potential candidates for adRP gene therapy.
We used transgenic mice expressing the ER stress-activated indicator (ERAI) and hT17M Rho to evaluate the activation of ER stress responses. Quantitative reverse transcription PCR (qRT-PCR) was used to analyze changes in the expression of 30 unfolded protein response (UPR)-associated genes at P12, 15, 18, 21, and 25. The cytosolic fraction of hT17M Rho retinal cells was used to measure the release of cytochrome C and apoptotic inducing factor-1 (AIF1) by Western blotting. Optical coherence tomography (OCT) analysis was performed for 1-month-old hT17M Rho mice.
hT17M Rho was localized in the outer nuclear layer (ONL) of T17M+/−ERAI+/− photoreceptors as well as C57BL/6 retinas injected with AAV-hT17M Rho-GFP. In P15 hT17M Rho retinas, we observed an up-regulation of UPR genes (Atf4, Eif2α, Xbp1, Bip, Canx, and Hsp90), autophagy genes and proapoptotic Bcl2 genes. OCT, and the downregulation of Nrl and Crx gene expression confirmed that cell death occurs in 55% of photoreceptors via the up-regulation of caspase-3 and caspase-12, and the release of AIF1 from the mitochondria.
The ER stress response is involved in retinal degeneration in hT17M Rho mice. The final demise of photoreceptors occurs via apoptosis involving ER stress-associated and mitochondria-induced caspase activation. We identified Atg5, Atg7, Bax, Bid, Bik, and Noxa as potential therapeutic targets for adRP treatment.
Mutations in the rhodopsin gene (Rho) were the first genetic components to be implicated in autosomal dominant retinitis pigmentosa (adRP).1 T17M rhodopsin is an example of a class II mutant opsin with a defect in protein folding.2 The substitution of threonine to methionine at position 17 occurs so close to the N2–N15 glycosylation site that it presumably affects the folding of the protein.3 Previous in vitro studies have shown that bovine T17M Rho partially reconstitutes with 11-cis-retinal and is transported to the cell membrane,4 whereas human T17M Rho preferably accumulates in the endoplasmic reticulum (ER), and binds poorly to the chromophore.5 In contrast, in vivo studies in Xenopus laevis have shown that glycosylation is not crucial for rhodopsin biosynthesis or trafficking.3 Recently, a difference between the in vitro and in vivo expression of N-terminally truncated fragments of human wild-type Rho has been examined carefully.6 The truncated Rho has been shown to remain in the ER in vitro, whereas it can be trafficked to the rod outer segments (ROS) in vivo. Therefore, an analysis of prior studies allows us to conclude that T17M mutant rhodopsin behaves differently in vitro and in vivo, and can abolish the N-terminal glycosylation site and relocate to the ROS. To find the exact mechanism by which the human T17M mutant causes the disease, it is important to monitor the progression of adRP in a system that mimics the human disease closely, such as in hT17M Rho transgenic mice. In addition, if our study shows that a mutant protein remains in the ER, the next step would be to examine the activity of the unfolded protein response (UPR) or ER stress response in hT17M Rho retinas.
ER stress initiates three transduction pathways, the PERK, ATF6, and IRE signaling pathways, which can confer protective and pro-apoptotic effects during ER stress.7 Recently, the UPR has attracted growing attention from researchers investigating the mechanism underlying retinitis pigmentosa (RP) in animal models.8–10 Moreover, it has become clear that the response to ER stress can be modulated therapeutically at three major levels: 1) upstream of ER stress sensors, by decreasing the amount of misfolded rhodopsin, 2) at the level of ER stress sensors, by attenuating their activation, and 3) downstream of ER stress transducers, by modulating the interaction network responsible for the implementation of ER stress.11 In hT17M Rho retinas, the role of the UPR has not been studied to our knowledge. Therefore, we are interested in elucidating the role of ER stress responses in the death of hT17M Rho photoreceptors to validate new therapeutic targets for adRP treatment. We analyzed transgenic retinas to determine whether the hT17M mutant triggers the UPR and whether the activation of the UPR promotes ER-stress-associated apoptosis. In our study, we determined the localization of a mutant form of rhodopsin in vivo, directly monitored ER stress in vivo using ER stress-activated indicator (ERAI) transgenic mice,12 and established a dynamic link between ER stress and the activation of other pro- and anti-apoptotic pathways. To our knowledge, our study is the first comprehensive analysis of the cellular pathways involved in the pathogenesis of hT17M Rho photoreceptors that identifies future targets for adRP gene therapy.
Transgenic mice expressing human T17M Rho, C57BL/6 mice, and ERAI mice were used for this study. The animal protocol was approved by the University of North Texas Health Center Animal Care and Use Committee, and was conducted following animal guidelines according to the ARVO statement for the Use of Animals in Ophthalmic and Vision Research. All animals were reared with 12-hour day and night cycles at a light intensity of less than 10 lux, as measured with a light meter (model 401036; Extech, Waltham, MA), since the light exposure is known to affect retinal function and morphology of hT17M Rho mice.13 To demonstrate that the hT17M transgene caused the ER stress, we crossed T17M+/− mice with ERAI+/− mice expressing an XBP1-GFP fusion gene (purchased from Riken Co., Tokyo, Japan). Eyes from F1 progeny with the genotypes T17M+/− ERAI+/− T17M−/− ERAI+/−, and CB57L6 were inoculated and fixed as described previously.14 GFP expression was detected using direct fluorescence or immunohistochemistry in 12 μm cryostat retina sections. As a positive control, 1 μL of a 2 mg/mL tunicamycin solution was injected subretinally into T17M−/− ERAI+/− mice. Eyes were collected 24 hours after injection for further analysis.
Mouse tails were collected, and the DNA was extracted using a 2.0× Taq RED Master Mix Kit (Apex, San Diego, CA). To identify the T17M+/− genotype, PCR was performed with human rhodopsin-specific primers (sense: 5′-GAGTGCACCCTCCTTAGGCA-3′ and anti-sense: 5′-TCCTGACTCGAGGACCCTAC-3′). The presence of a single band of ~300 base pairs (bp) signified a positive result. To identify the ERAI+/− genotype, PCR was performed using four primers (primer 1, 5′-GAACCAGGAGTTAAGACAGC-3′; primer 2, 5′-GAACAGCTCCTCGCCCTTGC-3′; primer 3, 5′-CTAGGCCACAGAATTGAAAGATCT-3′, and primer 4, 5′-CATGGTGGAAATTCTAGCATCATCC-3′). Primers 1 and 2 amplified a 240 bp fragment indicating the presence of the fusion transgene. Primers 3 and 4 provided an internal control and amplified a 324 bp fragment. The presence of two bands indicated a positive result.
Whole retinas were collected from individual T17M+/− (referred to as hT17M Rho mice from here on) and wild-type sibling pups at postnatal (P) days 12, 15, 18, 21, and 25. RNA was extracted using RNeasy mini prep kits (Qiagen, Valencia, CA). After treating the RNA with DNaseI (Invitrogen, Grand Island, NY), it was converted to cDNA using Super Script II Reverse Transcriptase (Invitrogen).
We used a custom Taqman array plate with 32 genes, including Gapdh as endogenous controls (Applied Biosystems, Carlsbad, CA). qRT-PCR was performed using ~50 ng of cDNA mixed with TaqMan universal PCR master mix (Applied Biosystems) and the StepOnePlus Real-Time PCR system (Applied Biosystems, N = 4 for each time point). The fold changes were calculated by dividing the mean of the relative quantities (RQs) for the hT17M Rho mice by the mean RQ of the wild-type mice at each time point.
Immunostaining of cryostat sections of retinas was performed as described15 using anti-GFP (Abcam, Cambridge, MA) and anti-rhodopsin 1D4 antibodies (University of British Columbia, Vancouver, BC, Canada). Cy-5- and Cy-2-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) were used to identify the localization of the GFP and rhodopsin proteins. Propidium iodide (Vector Laboratories, Inc., Burlingame, CA) was used to stain the nuclei of the retina cells. Images of the retinas were obtained using confocal microscopy.
The cytosolic fractions of three individual retinas from wild-type and transgenic mice were isolated using the Mitochondria Isolation Kit for Tissues (Thermo Scientific, Inc., Rockford, IL) and the Dounce stroke method, as recommended by the manufacturer. The protein concentration of each fraction was measured using a Biorad protein assay, and 40 μg of total protein were loaded on 12% SDS-PAGE gel (Biorad, Hercules, CA). Specific antibodies were used to detect cytochrome C (Santa-Cruz Biotechnology Inc., Santa Cruz, CA) and apoptotic inducing factor-1 (AIF1; Santa-Cruz Biotechnology Inc.). The membrane then was stripped, and β-actin (Sigma-Aldrich, St. Louis, MO) was detected as an internal control. The protein detection was performed using an infrared secondary antibody and an Odyssey infrared imager (Li-Cor Biosciences Inc., Lincoln, NE). The absence of mitochondrial contamination in the cytoplasmic fractions was confirmed by Western blot using an anti-Cox IV antibody (Abcam).
Additionally, Western blotting was performed to detect the UPR markers. Total protein was isolated from wild-type and transgenic retinas, and protein concentration was measured as above. Specific antibodies were used to detect Bip (Santa-Cruz Biotechnology Inc.), CHOP (Abcam), ATF6 (Imgenex Corp., San Diego, CA), and pEif2α (Cell Signaling Technology, Danvers, MA). The membrane then was stripped and β-actin was detected as internal control.
At 1 month of age, hT17M Rho mice and their wild-type (T17M−/−) siblings (N = 4) were anesthetized with intraperitoneal injections of 50 mg/kg ketamine and 50 mg/kg xylazine. Each mouse's pupils were dilated with 2.5% phenylephrine hydrochloride, and Systane Ultra was applied to both eyes after a few minutes. We measured the thickness of the outer nuclear layer (ONL) of the retina using the Bioptigen Spectral Domain Ophthalmic Imaging System (SDOIS) (Durham, NC). Six calibrated calipers were placed in the superior and inferior hemispheres of the retina within distances of 100, 200, 300, and 400 μm from the optic nerve head.
Two-way ANOVA (GraphPad Software, Inc., La Jolla, CA) was used to analyze the RQs obtained from the qRT-PCR and OCT data. A t-test was used to analyze a normalized protein content in retinal protein extracts of hT17M Rho and wild-type mice. A P value higher than 0.05 was considered significant.
ERAI mice carry venus, a variant of green fluorescent protein fused with a partial sequence of human Xbp1 that includes the 26 nucleotide (nt) ER-stress-specific intron.12 Under stress conditions, the Xbp1-venus fusion mRNA undergoes alternative splicing to remove the 26 nt intron, which puts venus in frame and results in the expression of green fluorescent protein (GFP). In our experiment, we observed green fluorescence in the ONL of T17M+/− ERAI+/− photoreceptors (Fig. 1) at P15, suggesting that the ER stress response is activated by this time point and that the mutant hT17M Rho causes ER stress. No fluorescence was observed in the ERAI+/− and T17 M+/− retinas.
Next, we injected subretinally ERAI+/− retinas with a solution of tunicamycin (ER stress inducer) 24 hours before performing immunohistochemical analysis and observed fluorescence in the injected retinas. This confirmed that the fluorescent signal detected in T17M+/− ERAI+/− retinas was a result of an activated ER stress response. In T17M+/− ERAI+/− retinas, we also found that rhodopsin was retained partially within the ER. Similar localization was observed in C57BL/6 retinas injected with AAV5-hT17M Rho-GFP (Supplementary Fig. S1, http://www.iovs.org/content/53/7/3792/suppl/DC1).
The first UPR gene to show up-regulation was Bip at P15. Bip is a molecular chaperone that recognizes misfolded proteins. Its expression was increased ~ 1.5-fold compared to the wild-type (control) at P15 (P < 0.0001, Fig. 2, Supplementary Table S1, http://www.iovs.org/content/53/7/3792/suppl/DC1). However, at P18 and P21, no significant difference in Bip expression was observed. Bip expression was elevated significantly again at P25 (an increase of 1.5-fold compared to the control, P < 0.01). Other chaperones, such as Calnexin (Cnx) and Hsp90B1, also showed increased expression (Fig. 2, Supplementary Table S1, http://www.iovs.org/content/53/7/3792/suppl/DC1). Expression of Cnx was increased in hT17M Rho mice 1.3-, 1.3-, 1.6-, and 1.8-fold at P15, P18, P21, and P25, respectively (P < 0.01, P < 0.05, P < 0.0001, and P < 0.0001, respectively). Conversely, Hsp90B1 was not significantly up-regulated after P15 (1.4-fold increase, P < 0.01). The Eif2α gene also was significantly up-regulated at P15 and P18 (~1.2- and ~1.3-fold increase, P < 0.05 and P < 0.01, respectively). Atf4 gene expression, another marker of the PERK pathway that is translated preferentially by phosphorylated Eif2α, was elevated significantly at P15, P18, and P21 (~1.4-fold increase, P < 0.05 for all time points) and then declined with time. Interestingly, CHOP, which is a target of the ATF4 transcription factor, already was over-expressed at P12 (~1.3-fold increase, P < 0.01). Its expression at P15 was increased 1.5-fold (P < 0.001). At this time point, expression of the Eif2α and Atf4 genes (PERK pathway) already was elevated. Atf6 gene expression (ATF6 pathway) was modulated at all time points; however, it was not significantly different from that in the control. Xbp1 gene expression (IRE1 pathway) was increased significantly from P15 (1.5-fold increase, P < 0.0001) until P25.
We verified further the activation of UPR by detecting the UPR markers, like Bip (~1.13-fold increase, P < 0.05), pEif2α (~1.24-fold increase, P < 0.05), and apoptotic inducer CHOP (~1.14-fold increase, P < 0.05) in hT17M Rho mice at P15 by Western blot analysis (Fig. 3). As observed at mRNA level, no significant difference in ATF6 protein expression was observed.
We analyzed mouse and human Rho gene expression in P12, P21, and P30 transgenic retinas, and found that during the adRP progression relative expression of the mouse Rho gene declined in time while expression of the human Rho gene was elevated steadily (Fig. 4, Supplementary Table S2, http://www.iovs.org/content/53/7/3792/suppl/DC1). Mouse Rho expression in hT17M Rho retina compared to that in wild-type retina was lowered from 0.83 at P12 to 0.38 at P30 (Supplementary Table S2, http://www.iovs.org/content/53/7/3792/suppl/DC1).
To estimate total Rho protein expression, we performed Western blot analysis and discovered that the “monomer” and “dimer” forms of Rho protein were reduced in P15 transgenic retinas by 28% (P = 0.014 and P = 0.009, respectively).
In hT17M Rho retinas, we detected modulations in expression levels of the autophagy-associated genes (Supplementary Fig. S3, http://www.iovs.org/content/53/7/3792/suppl/DC1) and Akt pathway genes (Supplementary Fig. S4, http://www.iovs.org/content/53/7/3792/suppl/DC1) during the adRP progression.
The pro-apoptotic members of the Bcl2 family, Bax, Bid, and Bik, were overexpressed in hT17M Rho retinas (Fig. 5, Supplementary Table S1, http://www.iovs.org/content/53/7/3792/suppl/DC1). Their expression was increased significantly by 1.2- to 2.5-fold compared to the control. The Bim and Noxa genes, however, were over-expressed significantly only at P18 and P21. Bim gene expression was up-regulated at P21 by 1.4-fold (P < 0.001), and Noxa gene expression was increased significantly by 1.5- and 1.8-fold at P18 and P21, respectively (P < 0.05 and P < 0.001).
The anti-apoptotic gene Bcl2 also was increased by 1.3- to 1.9-fold at all time points from P15 until P25 in hT17M Rho retinas except at P18.
Mitochondrial membrane integrity is crucial for cell survival, and mitochondrial outer membrane permeabilization (MOMP) is fatal for the cell. Members of the Bcl-2 family of proteins, such as Bax and Noxa, are known to induce MOMP. Therefore, we decided to isolate the cytoplasmic portion of hT17M Rho retinal cells from the mitochondria to analyze the presence of the AIF1 and cytochrome C proteins. Cytochrome C release from the mitochondria was not detected in hT17M Rho retinas, while AIF1 protein was present at significant levels (Fig. 6).
The executioner Casp3 also showed a ~ 1.4-fold increase at P15 (P < 0.01), and it remained up-regulated (Fig. 7A, Supplementary Table S1, http://www.iovs.org/content/53/7/3792/suppl/DC1). In addition, Casp12, which encodes the ER-resident caspase, was induced by 2.5-fold later in the ER stress cycle at P25 (P < 0.0001). We observed consistently a downregulation in the expression of Nrl, which is a transcriptional regulator of rod-specific genes. Starting from P15, its expression was reduced continuously by 42%, 67%, 45%, and almost 93% (P < 0.05, P < 0.01, P > 0.05, and P < 0.001, respectively, Fig. 7B, Supplementary Table S1, http://www.iovs.org/content/53/7/3792/suppl/DC1) Similarly, Crx, which also is a photoreceptor-specific transcriptional factor, showed lower expression at P18 (38% reduction, P < 0.001) and P25 (62% reduction, P < 0.0001). We also examined the thickness of the outer nuclear layer in retinas from 1-month-old hT17M Rho mice and their wild-type siblings using OCT. The results of the OCT analysis demonstrated a reduction of approximately 50% (P < 0.0001) in the length of the ONL in hT17M Rho mice (Fig. 7C).
The hT17M Rho transgenic mouse model is a very useful tool for understanding the activation of ER stress in adRP. T17M mutant rhodopsin has been described previously in cell lines and X. laevis, and to our knowledge this is the first time it has been studied in a mammalian model. We confirm that the mutant hT17M Rho induces ER stress in the T17M+/− ERAI+/− mice at P15 due to its retention within the ER or mislocalization to the cytoplasm (Fig. 1). Further study using specialized microscopic techniques will be required to determine whether the mutant protein forms agglomerates in the cytoplasm of hT17M Rho cells.
Consistent with our immunohistological analysis of T17M+/− ERAI+/− retinas demonstrating the splicing of the Xbp1 mRNA and activation of the IRE pathway, we found that several genes involved in UPR are over-expressed at P15 in hT17M Rho transgenic retinas. Results of the protein analysis also confirm the activation of the UPR in transgenic retina. For example, the PERK signaling is activated in P15 hT17M Rho retina. However, the ATF6 pathway is not modified.
It is important to note here that the hT17M Rho mouse model has an extra copy of Rho. To confirm that this induction of UPR genes was not due to Rho overdose but rather the mutant human transgene, we analyzed the hT17M Rho mice carrying one copy of mouse Rho gene (T17M+/− Rho+/−), which were not available for us at the time of the original experiment. Interestingly, these mice demonstrated the same level of modulation of the UPR-associated gene expression compared to hT17M Rho (Supplementary Fig. S2, Supplementary Table S3. http://www.iovs.org/content/53/7/3792/suppl/DC1). In T17M+/− Rho+/− mice, we observed up-regulation of the UPR genes along with elevated Bcl2 family and apoptotic genes expression as early as P15 (Supplementary Fig. S2, http://www.iovs.org/content/53/7/3792/suppl/DC1).
Elevation of UPR-associated gene expression also was observed in wild-type retinas injected subretinally with AAV5-hT17M Rho-GFP when compared to AAV5-hRho-GFP injections (Supplementary Fig. S1, Supplementary Table S4, http://www.iovs.org/content/53/7/3792/suppl/DC1). To support our model further, we checked expression of hRho (transgene) and mRho (endogenous Rho) in T17M Rho and C57BL/6 retinas at P12, P21, and P30 (Fig. 4). Surprisingly, we observed that when the mRho expression declines, the hRho expression increases suggesting a compensatory effect. The total Rho protein in hT17M Rho, however, was lower compared to wild-type at P15 (Fig. 4) indicating that the hT17M Rho photoreceptors do not over-produce Rho protein.
In hT17M Rho, increases in the expression of the molecular chaperones Bip, Cnx, and Hsp901B, suggesting that the hT17M Rho ER is overloaded with misfolded proteins, and this overload leads to the activation of ER stress responses (Fig. 2). Markers of the PERK and IRE1 pathways are up-regulated in hT17M Rho retinas. For example, expression of the eIf2α and Atf4 genes increases starting at P15. However, the downstream marker, Chop gene, is up-regulated significantly by P12, earlier then the expression of its upstream regulators. The basal level of peIf2α protein appears to be sufficient to stimulate the transcription of the nuclear factor ATF4. Even a slight up-regulation of ATF4 at P12 is sufficient to induce the expression of the Chop gene. The IRE1 pathway also is up-regulated in hT17M Rho retinas by P12. However, it is induced only significantly at P15, which correlates with our immunohistochemical data on splicing of the Xbp1 mRNA (Fig. 1). The ATF6 pathway does not show any specific trend and does not appear to have a significant role in hT17M Rho degeneration (Fig. 3). Therefore, our immunohistochemical, gene expression, and Western blot analyses suggest that ER stress is activated in hT17M Rho retinas.
An analysis of ERAD gene expression shows no significant changes compared to the control (Supplementary Table S1, http://www.iovs.org/content/53/7/3792/suppl/DC1). However, the autophagy degradation pathway is up-regulated in hT17M Rho retinas starting at P15 (Supplementary Fig. S3, http://www.iovs.org/content/53/7/3792/suppl/DC1). This up-regulation appears to be connected to the over-expression of the UPR and Atf4 genes that has been shown to induce autophagy.16 At this point, it is not clear whether autophagy exerts a pro-survival effect in hT17M Rho retinas by degrading mutant agglomerates or promotes a pro-death, non-apoptotic form of programmed cell death involving the bulk degradation of the cytoplasmic contents. Additional experiments to analyze hT17M Rho retinas lacking the Atg5 or Atg7 genes will be necessary to answer this question.
BH3-only proteins are regarded as the initial responders to incoming stress signals.17 In our experiments, we observed the overexpression of Bax, Bid, Bim, Bik, and Noxa during ER stress, which suggests that pro-apoptotic stimuli are induced in hT17M Rho photoreceptors. Over-expression of BH3-only genes appears to be related to p53 activation in hT17M Rho retinas. A link between ER stress and the activation of p53 has been proposed recently.18 Bax and Bik also have been shown to be regulated translationally by p53,19,20 and the release of Bid proteins from Bcl-xL sequestration can occur in a p53-dependent manner.21 These data indicate the need for further study of p53 activation in hT17M Rho retinas.
The mechanisms by which pro-apoptotic activation occurs include posttranslational alterations, such as phosphorylation (Bad and Bik/Nbk) or proteolytic cleavage (the truncation of Bid by caspase-8).17 Therefore, we next asked the question: “Is there a direct link between overproduction of these proteins and their activation”? Based on our results, there does appear to be a connection. Our analysis of the retinal mitochondrial fraction shows a 55% increase in the release of AIF1 from the hT17M Rho mitochondria, indicating that the mitochondria permeability transition pore (MPTP) already exists by P21. This result implies that the over-expression of BH3-only proteins correlates with an increase in their post-translational modification.
Pro-survival markers, such as Akt signaling and Bcl2 over-expression, are present in hT17M Rho retinas. Akt signaling controls the dissociation of Bad protein from the Bcl-2/Bcl-X complex and the loss of its pro-apoptotic function.22 In our experiments, Bad gene expression was found not to be elevated in hT17M Rho retinas, and it is possible that the Akt-controlled posttranscriptional phosphorylation of Bad affects its transcriptional level. Another signaling molecule, the anti-apoptotic gene Bcl-2, is up-regulated in hT17M Rho retinas after P12, at which point the expression of the Chop gene already is increased. The Bcl-2 gene is known to be a transcriptional control target of the CHOP transcriptional factor.23 Therefore, after P15, when Chop expression decreases, Bcl2 gene expression increases. Both pro-survival pathways are up-regulated in hT17M Rho retinas in an attempt to balance the expression of pro-apoptotic Bcl2 proteins and restore homeostasis in hT17M Rho photoreceptors. Simultaneous activation of pro- and anti-apoptotic pathways in our experiment, however, could be accounted for by different dynamics of degeneration in different retinal cell types. For example, while rod photoreceptors already are undergoing suicide by apoptosis, neighboring cells, such as cone photoreceptors and retinal ganglia cells, still are struggling to prevent apoptosis.
Finally, we found that ER stress and mitochondria-associated apoptosis lead to the final demise of photoreceptors (Figs. 6, ,7A).7A). Both caspase-3 and caspase-12 are up-regulated. However, caspase-3 is up-regulated earlier than caspase-12, suggesting that other cellular pathways lead to the activation of the executioner caspase. These findings are consistent with the rate of adRP progression in transgenic retinas measured by OCT (Fig. 7C). At 1 month, transgenic mice already have lost 50% of their photoreceptors, resulting in the downregulation of the transcriptional factors Nrl and Crx starting as early as P15 and P18. These changes apparently are responsible for decrease in the level of Rho protein in hT17M Rho retina.
To our knowledge, for the first time, we demonstrated that the ER stress response is involved in retinal degeneration in hT17M Rho retinas, and correlates strongly with the up-regulation of autophagy markers and the activation of mitochondrial signaling via the up-regulation of pro-apoptotic Bcl2 genes. The results of our experiments allow us to identify the following genes that could be potential therapeutic targets for adRP treatment: Atg5, Atg7, Bax, Bid, Bik, and Noxa.
The Riken Bioresource Center, Tokyo, Japan provided the ERAI mice.
Supported by National Institutes of Health Grant R01EY020905, Foundation Fighting Blindness Grant TA-GT-0409-0508-NTERI, a Hope for Vision grant, and DOD Grant W81XH-10-2-0003.
Disclosure: M.M. Kunte, None; S. Choudhury, None; J.F. Manheim, None; V.M. Shinde, None; M. Miura, None; V.A. Chiodo, None; W.W. Hauswirth, None; O.S. Gorbatyuk, None; M.S. Gorbatyuk, None